Oncology

MedTech News for BD, Icentia, Bone Biologics, Compal Electronics, Avation Medical, Cardiovascular Systems

Notizia - Recent Pharma, Healthcare and Biotech Happenings

BD’s Advanced Ultrasound Technology for IV Insertions; Compal Electronics Launched New RFA System AblatePal; Icentia Received Clearance for CardioSTAT; Avation Medical Announced Clearance for the Vivally® System; Cardiovascular Systems’s ECLIPSE Clinical Trial; Bone Biologics Received Approval to for Pilot Trial with NB1 in Spinal Fusion Patients

BD Introduced Advanced Ultrasound Technology for IV Insertions to Help Drive First-Stick Success On April 11, 2023, BD (Becton, Dickinson, and Company), a leading global medical technology company, announced the launch of a new, easy-to-use advanced ultrasound device with a specialized probe designed to provide clinicians with optimal IV placement. The BD Prevue™ II System uses real-time needle depth markers to fill a gap in IV access. The device is compatible with catheters that support the BD Cue™ Needle Tracking System, which provides a high-quality ultrasound image of the needle trajectory. Simulated studies suggest that combining an ultrasound...

Explore More...

Latest-pharma-happenings-for-rallybio-sanofi-eureka-lilly-unity-biotechnology

Unity’s advanced vascular eye disease trial; Rallybio raises $100 M; Sanofi bets over $1B for Eureka’s candidate; Lilly invests in MiNA;

pharma-happenings-for-arrowhead-sartorius-sirnaomics-agc-biologics

Arrowhead’s ARO-ENaC Clinical Trial; Sartorius Acquires Stake in CellGenix; AGC Biologics’s Cell & Gene Therapy; Sirnaomics Secures $105 Million

Horizon-Arrowhead-deal-Dr-Reddy-Lab-Drug-US-Launch-Targovax-ONCOS-102;-RedHill-Oral-Opaganib-COVID-19

Amgen a leader in Undruggable Lung Cancer; Verrica’s Skin Disease Drug Delays; Fennec’s Faith in its Chemotherapy-Induced Hearing Loss Drug; Nexturn Bio’s Acquisition of RosVivo

Another Failed NASH Drug; Takeda’s Dengue Shot; Innovent’s Cholangiocarcinoma Clinical Trial; TLX66 in AL Amyloidosis

TLX66 in AL Amyloidosis; Takeda’s Dengue Shot; Innovent’s Cholangiocarcinoma Clinical Trial; Another Failed NASH Drug

recent-pharma-biotech-news-updates-for-sanofi-gsk-apellis-innocare-landos

InnoCare’s Trial In China; Sanofi/GSK COVID-19 Vaccine; Apellis’s Empaveli for PNH; LianBio, Landos Collab

recent-pharma-happenings-for-eli-lilly-mina-appia-bio-nuvalent

Lilly ink deal with MiNA; Appia Bio aims for CAR-T with $52M raise; Nuvalent raises $135M; Orchard gene therapy benefits kids

recent-pharma-biotech-news-updates-happenings-for-abbott-biogen-eli-lilly-arch-oncology

Arch Oncology scores $105M; Abbott’s new coronary imaging platform; Lilly scraps IL-23 psoriasis program; Biogen offer access to experimental ALS med

recent-biotech-pharma-lifescience-industry-news-updates-for-adagio-lyndra-bms-anixa

Adagio Raises $336 M; Lyndra’s Schizo Trial; BMS Opdivo for Gastric Cancer; Anixa Ovarian Cancer CAR-T Therapy

Ewing Sarcoma: Key Companies and Emerging Therapies in the Landscape

recent-pharma-happenings-for-recursion-repertoire-cequr-eli-lilly

Lilly’s Retevmo shows promise; CeQur tanks up on $110M in funding; Repertoire secures $189M; Recursion sets terms for $306M IPO

recent-pharma-news-and-updates-for-astrazeneca-sanofi-taysha

Taysha Acquires Rare Disease Gene Therapy For $5.5 M; AZ’s Farxiga Fails In COVID-19 Study; Sanofi To Strengthen Its Vaccines Manufacturing Capacities

Cancer Anorexia Market | Cancer Anorexia Pipeline

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Oncology

Unity’s advanced vascular eye disease trial; Rallybio raises $100 M; Sanofi bets over $1B for Eureka’s candidate; Lilly invests in MiNA;

Arrowhead’s ARO-ENaC Clinical Trial; Sartorius Acquires Stake in CellGenix; AGC Biologics’s Cell & Gene Therapy; Sirnaomics Secures $105 Million

Horizon/ Arrowhead Deal; Dr Reddy’s Lab’s Drug US Launch; Targovax’s ONCOS-102; RedHill’s Oral Opaganib in COVID-19

Mallinckrodt earns FDA nod for skin therapy; RayzeBio secures $108M; VectorY raises $38M; Umoja banks $210M

Aelis Farma pockets $30M; Alcyone unveils $23M for AAV gene therapies; Progentec and GSK collaborate; Kozin bags $60M

Diagnosis Delays, Ineffective Treatment Options Plaque the Bone Cancer Market Growth

Amgen a leader in Undruggable Lung Cancer; Verrica’s Skin Disease Drug Delays; Fennec’s Faith in its Chemotherapy-Induced Hearing Loss Drug; Nexturn Bio’s Acquisition of RosVivo

TLX66 in AL Amyloidosis; Takeda’s Dengue Shot; Innovent’s Cholangiocarcinoma Clinical Trial; Another Failed NASH Drug

More Views & Analysis

InnoCare’s Trial In China; Sanofi/GSK COVID-19 Vaccine; Apellis’s Empaveli for PNH; LianBio, Landos Collab

Lilly ink deal with MiNA; Appia Bio aims for CAR-T with $52M raise; Nuvalent raises $135M; Orchard gene therapy benefits kids

Arch Oncology scores $105M; Abbott’s new coronary imaging platform; Lilly scraps IL-23 psoriasis program; Biogen offer access to experimental ALS med

Adagio Raises $336 M; Lyndra’s Schizo Trial; BMS Opdivo for Gastric Cancer; Anixa Ovarian Cancer CAR-T Therapy

Ewing Sarcoma: Key Companies and Emerging Therapies in the Landscape

Lilly’s Retevmo shows promise; CeQur tanks up on $110M in funding; Repertoire secures $189M; Recursion sets terms for $306M IPO

Taysha Acquires Rare Disease Gene Therapy For $5.5 M; AZ’s Farxiga Fails In COVID-19 Study; Sanofi To Strengthen Its Vaccines Manufacturing Capacities

Limited Therapeutics Options and A Weak Pipeline: What Lies Ahead in the Cancer Anorexia Market?

Subscribe to our Updates

Daily

Weekly

Monthly